BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Clinical Outcome
86 results:

  • 1. Adrenal incidentalomas, cortisol secretion and cancer: is there a real crosstalk?
    Herrera-Martínez AD; Román ÁR; Corrales EP; Idrobo C; Ramírez PP; Rojas PM; Lázaro CR; Araujo-Castro M
    Front Endocrinol (Lausanne); 2023; 14():1335202. PubMed ID: 38264281
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Does commission on cancer (CoC) accreditation mitigate the effect of care fragmentation on clinical outcome in localized rectal cancer?
    Park SS; Verm RA; Abdelsattar ZM; Kramer S; Swanson J; Fernando M; Cohn T; Luchette FA; Baker MS
    Am J Surg; 2024 Apr; 230():63-67. PubMed ID: 38148258
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Effects of systemic inflammation and frailty on survival in elderly cancer patients: Results from the INSCOC study.
    Zhang Q; Wang Z; Song M; Liu T; Ding J; Deng L; Zhang X; Qian L; Ge Y; Xie H; Ruan G; Song C; Yao Q; Xu H; Ju H; Shi H
    Front Immunol; 2023; 14():936904. PubMed ID: 36891320
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic and predictive value of Immunoscore and its correlation with ctDNA in stage II colorectal cancer.
    Wang F; Lu S; Cao D; Qian J; Li C; Zhang R; Wang F; Wu M; Liu Y; Pan Z; Wu X; Lu Z; Ding P; Li L; Lin J; Catteau A; Galon J; Chen G
    Oncoimmunology; 2023; 12(1):2161167. PubMed ID: 36632564
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. clinical outcome after total neoadjuvant treatment (CAO/ARO/AIO-12) versus intensified neoadjuvant and adjuvant treatment (CAO/ARO/AIO-04) a comparison between two multicenter randomized phase II/III trials.
    Diefenhardt M; Fleischmann M; Martin D; Hofheinz RD; Piso P; Germer CT; Hambsch P; Grützmann R; Kirste S; Schlenska-Lange A; Ghadimi M; Rödel C; Fokas E;
    Radiother Oncol; 2023 Feb; 179():109455. PubMed ID: 36572280
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. outcome of self-expandable metal stents placement for obstructive colorectal cancer: 7 years' experience from a Swedish tertiary center.
    Papachrysos N; Shafazand M; Alkelin L; Kilincalp S; de Lange T
    Surg Endosc; 2023 Apr; 37(4):2653-2658. PubMed ID: 36401103
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comparison of open, laparoscopic, and robotic left colectomy for radical treatment of colon cancer: a retrospective analysis in a consecutive series of 211 patients.
    Huang Z; Li T; Zhang G; Zhou Z; Shi H; Tang C; Yang L; Lei X
    World J Surg Oncol; 2022 Oct; 20(1):345. PubMed ID: 36253768
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Routine postoperative CT to detect anastomotic leakage after low anterior resection for rectal cancer has a low sensitivity and specificity and a poor interobserver agreement.
    Lynglund OM; Ellebæk MB; Al-Dakhiel Z; Wied Greisen P; Schnack Brandt Rasmussen B; Graumann O; Möller S; Bjarke Rahr H; Qvist N
    Clin Radiol; 2022 Oct; 77(10):e719-e722. PubMed ID: 35715242
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Development of a Fully Automated Method to Obtain Reproducible Lymphocyte Counts in Patients With colorectal cancer.
    Fiehn AK; Reiss B; Gögenur M; Bzorek M; Gögenur I
    Appl Immunohistochem Mol Morphol; 2022 Aug; 30(7):493-500. PubMed ID: 35703148
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience.
    Boccaccino A; Borelli B; Intini R; Antista M; Bensi M; Rossini D; Passardi A; Tamberi S; Giampieri R; Antonuzzo L; Noto L; Roviello G; Zichi C; Salati M; Puccini A; Noto C; Parisi A; Rihawi K; Persano M; Crespi V; Libertini M; Giordano M; Moretto R; Lonardi S; Cremolini C
    ESMO Open; 2022 Jun; 7(3):100506. PubMed ID: 35696748
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Impact of Modern Management Strategies on the clinical outcome of Patients With Low Rectal cancer - A Retrospective, Monocentric Cohort Study.
    Karam E; Sindayigaya R; Giger-Pabst U; Gabriel M; Michot N; Courtot L; Tabchouri N; Moussata D; Lecomte T; Chapet S; Calais G; Bourlier P; Salamé E; Ouaissi M
    Anticancer Res; 2022 Apr; 42(4):1949-1963. PubMed ID: 35347015
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Comparison of
    Tsai HL; Chen YC; Yin TC; Su WC; Chen PJ; Chang TK; Li CC; Huang CW; Wang JY
    Oncol Res; 2022 May; 29(1):47-61. PubMed ID: 35177165
    [No Abstract]    [Full Text] [Related]  

  • 13. New Circulating Circular RNAs with Diagnostic and Prognostic Potential in Advanced colorectal cancer.
    Radanova M; Mihaylova G; Tasinov O; Ivanova DP; Stoyanov GS; Nazifova-Tasinova N; Manev R; Salim A; Nikolova M; Ivanova DG; Conev N; Mihaylova Z; Donev I
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948079
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Image-based assessment of extracellular mucin-to-tumor area predicts consensus molecular subtypes (CMS) in colorectal cancer.
    Nguyen HG; Lundström O; Blank A; Dawson H; Lugli A; Anisimova M; Zlobec I
    Mod Pathol; 2022 Feb; 35(2):240-248. PubMed ID: 34475526
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genetic Variants of
    Gaibar M; Galán M; Romero-Lorca A; Antón B; Malón D; Moreno A; Fernández-Santander A; Novillo A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573134
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. CD30
    Lam JH; Hong M; Koo SL; Chua CWL; Lim KL; Wee F; Wan WK; Leow WQ; Yeo JG; Tan IBH; Yeong J; Lim TKH; Lim TS
    Cancer Immunol Immunother; 2021 Aug; 70(8):2353-2365. PubMed ID: 33527196
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Immune phenotype and histopathological growth pattern in patients with colorectal liver metastases.
    Stremitzer S; Vermeulen P; Graver S; Kockx M; Dirix L; Yang D; Zhang W; Stift J; Wrba F; Gruenberger T; Lenz HJ; Scherer SJ
    Br J Cancer; 2020 May; 122(10):1518-1524. PubMed ID: 32205863
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Tumour-infiltrating CD8
    Glaire MA; Domingo E; Sveen A; Bruun J; Nesbakken A; Nicholson G; Novelli M; Lawson K; Oukrif D; Kildal W; Danielsen HE; Kerr R; Kerr D; Tomlinson I; Lothe RA; Church DN
    Br J Cancer; 2019 Sep; 121(6):474-482. PubMed ID: 31388185
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Frequent rectal gastrointestinal stromal tumor recurrences in the imatinib era: Retrospective analysis of an International Patient Registry.
    Stuart E; Banerjee S; de la Torre J; Wang Y; Scherzer N; Burgoyne AM; Parry L; Fanta PT; Ramamoorthy S; Sicklick JK
    J Surg Oncol; 2019 Sep; 120(4):715-721. PubMed ID: 31297829
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. DNA mismatch repair deficiency but not ARID1A loss is associated with prognosis in small intestinal adenocarcinoma.
    González I; Goyal B; Xia MD; Pai RK; Ma C
    Hum Pathol; 2019 Mar; 85():18-26. PubMed ID: 30381262
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.